Title: As Reported by the House Natural Resources Committee
Official Title: As Reported by the House Natural Resources Committee
Number of Sections: 33
Source: versions - As Reported by the House Natural Resources Committee
Media Type: application/pdf
Strikethrough Detection: 26 sections found

================================================================================

Section 1:
136th General Assembly
Regular Session Am. S. B. No. 152
2025-2026
Senator Brenner
Cosponsors: Senators Lang, Cirino, DeMora, Hicks-Hudson, Liston, Patton,
Reineke, Roegner
Representative Mathews, T.
To amend sections 4729.01, 4729.36, 4729.531, 1

Section 2:
4729.532, 4729.54, and 4729.55 of the Revised 2
Code to allow wild animal rehabilitation 3
facilities to receive a limited license to 4
administer euthanasia drugs and to modify the 5
law regarding the use of terms that are limited 6
to pharmacies and pharmacists. 7
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:

Section 3:
Section 1. That sections 4729.01, 4729.36, 4729.531, 8

Section 4:
4729.532, 4729.54, and 4729.55 of the Revised Code be amended to 9
read as follows: 10
Sec. 4729.01. As used in this chapter: 11
(A) "Pharmacy," except when used in a context that refers 12
to the practice of pharmacy, means any area, room, rooms, place 13
of business, department, or portion of any of the foregoing 14
where the practice of pharmacy is conducted. 15
(B) "Practice of pharmacy" means providing pharmacist care 16
requiring specialized knowledge, judgment, and skill derived 17
Am. S. B. No. 152 Page 2
As Reported by the House Natural Resources Committee
from the principles of biological, chemical, behavioral, social, 18
pharmaceutical, and clinical sciences. As used in this division, 19
"pharmacist care" includes the following: 20
(1) Interpreting prescriptions; 21
(2) Dispensing drugs and drug therapy related devices; 22
(3) Compounding drugs; 23
(4) Counseling individuals with regard to their drug 24
therapy, recommending drug therapy related devices, and 25
assisting in the selection of drugs and appliances for treatment 26
of common diseases and injuries and providing instruction in the 27
proper use of the drugs and appliances; 28
(5) Performing drug regimen reviews with individuals by 29
discussing all of the drugs that the individual is taking and 30
explaining the interactions of the drugs; 31
(6) Performing drug utilization reviews with licensed 32
health professionals authorized to prescribe drugs when the 33
pharmacist determines that an individual with a prescription has 34
a drug regimen that warrants additional discussion with the 35
prescriber; 36
(7) Advising an individual and the health care 37
professionals treating an individual with regard to the 38
individual's drug therapy; 39
(8) Acting pursuant to a consult agreement, if an 40
agreement has been established; 41
(9) Engaging in the administration of immunizations to the 42
extent authorized by section 4729.41 of the Revised Code; 43
(10) Engaging in the administration of drugs to the extent 44
Am. S. B. No. 152 Page 3
As Reported by the House Natural Resources Committee
authorized by section 4729.45 of the Revised Code. 45
(C) "Compounding" means the preparation, mixing, 46
assembling, packaging, and labeling of one or more drugs in any 47
of the following circumstances: 48
(1) Pursuant to a prescription issued by a licensed health 49
professional authorized to prescribe drugs; 50
(2) Pursuant to the modification of a prescription made in 51
accordance with a consult agreement; 52
(3) As an incident to research, teaching activities, or 53
chemical analysis; 54
(4) In anticipation of orders for drugs pursuant to 55
prescriptions, based on routine, regularly observed dispensing 56
patterns; 57
(5) Pursuant to a request made by a licensed health 58
professional authorized to prescribe drugs for a drug that is to 59
be used by the professional for the purpose of direct 60
administration to patients in the course of the professional's 61
practice, if all of the following apply: 62
(a) At the time the request is made, the drug is not 63
commercially available regardless of the reason that the drug is 64
not available, including the absence of a manufacturer for the 65
drug or the lack of a readily available supply of the drug from 66
a manufacturer. 67
(b) A limited quantity of the drug is compounded and 68
provided to the professional. 69
(c) The drug is compounded and provided to the 70
professional as an occasional exception to the normal practice 71
of dispensing drugs pursuant to patient-specific prescriptions. 72
Am. S. B. No. 152 Page 4
As Reported by the House Natural Resources Committee
(D) "Consult agreement" means an agreement that has been 73
entered into under section 4729.39 of the Revised Code. 74
(E) "Drug" means: 75
(1) Any article recognized in the United States 76
pharmacopoeia and national formulary, or any supplement to them, 77
intended for use in the diagnosis, cure, mitigation, treatment, 78
or prevention of disease in humans or animals; 79
(2) Any other article intended for use in the diagnosis, 80
cure, mitigation, treatment, or prevention of disease in humans 81
or animals; 82
(3) Any article, other than food, intended to affect the 83
structure or any function of the body of humans or animals; 84
(4) Any article intended for use as a component of any 85
article specified in division (E)(1), (2), or (3) of this 86

Section 5:
section; but does not include devices or their components, 87
parts, or accessories. 88
"Drug" does not include "hemp" or a "hemp product" as 89
those terms are defined in section 928.01 of the Revised Code. 90
(F) "Dangerous drug" means any of the following: 91
(1) Any drug to which either of the following applies: 92
(a) Under the "Federal Food, Drug, and Cosmetic Act," 52 93
Stat. 1040 (1938), 21 U.S.C.A. 301, as amended, the drug is 94
required to bear a label containing the legend "Caution: Federal 95
law prohibits dispensing without prescription" or "Caution: 96
Federal law restricts this drug to use by or on the order of a 97
licensed veterinarian" or any similar restrictive statement, or 98
the drug may be dispensed only upon a prescription; 99
Am. S. B. No. 152 Page 5
As Reported by the House Natural Resources Committee
(b) Under Chapter 3715. or 3719. of the Revised Code, the 100
drug may be dispensed only upon a prescription. 101
(2) Any drug that contains a schedule V controlled 102
substance and that is exempt from Chapter 3719. of the Revised 103
Code or to which that chapter does not apply; 104
(3) Any drug intended for administration by injection into 105
the human body other than through a natural orifice of the human 106
body; 107
(4) Any drug that is a biological product, as defined in 108

Section 6:
section 3715.01 of the Revised Code. 109
(G) "Federal drug abuse control laws" has the same meaning 110
as in section 3719.01 of the Revised Code. 111
(H) "Prescription" means all of the following: 112
(1) A written, electronic, or oral order for drugs or 113
combinations or mixtures of drugs to be used by a particular 114
individual or for treating a particular animal, issued by a 115
licensed health professional authorized to prescribe drugs; 116
(2) For purposes of sections 4723.4810, 4729.282, 117

Section 7:
4730.432, and 4731.93 of the Revised Code, a written, 118
electronic, or oral order for a drug to treat chlamydia, 119
gonorrhea, or trichomoniasis issued to and in the name of a 120
patient who is not the intended user of the drug but is the 121
sexual partner of the intended user; 122
(3) For purposes of sections 3313.7110, 3313.7111, 123

Section 8:
3314.143, 3326.28, 3328.29, 4723.483, 4729.88, 4730.433, 124

Section 9:
4731.96, and 5101.76 of the Revised Code, a written, electronic, 125
or oral order for an epinephrine autoinjector issued to and in 126
the name of a school, school district, or camp; 127
Am. S. B. No. 152 Page 6
As Reported by the House Natural Resources Committee
(4) For purposes of Chapter 3728. and sections 4723.483, 128

Section 10:
4729.88, 4730.433, and 4731.96 of the Revised Code, a written, 129
electronic, or oral order for an epinephrine autoinjector issued 130
to and in the name of a qualified entity, as defined in section 131

Section 11:
3728.01 of the Revised Code; 132
(5) For purposes of sections 3313.7115, 3313.7116, 133

Section 12:
3314.147, 3326.60, 3328.38, 4723.4811, 4730.437, 4731.92, and 134

Section 13:
5101.78 of the Revised Code, a written, electronic, or oral 135
order for injectable or nasally administered glucagon in the 136
name of a school, school district, or camp. 137
(I) "Licensed health professional authorized to prescribe 138
drugs" or "prescriber" means an individual who is authorized by 139
law to prescribe drugs or dangerous drugs or drug therapy 140
related devices in the course of the individual's professional 141
practice, including only the following: 142
(1) A dentist licensed under Chapter 4715. of the Revised 143
Code; 144
(2) A clinical nurse specialist, certified nurse-midwife, 145
or certified nurse practitioner who holds a current, valid 146
license issued under Chapter 4723. of the Revised Code to 147
practice nursing as an advanced practice registered nurse; 148
(3) A certified registered nurse anesthetist who holds a 149
current, valid license issued under Chapter 4723. of the Revised 150
Code to practice nursing as an advanced practice registered 151
nurse, but only to the extent of the nurse's authority under 152

Section 14:
sections 4723.43 and 4723.434 of the Revised Code; 153
(4) An optometrist licensed under Chapter 4725. of the 154
Revised Code to practice optometry; 155
(5) A physician authorized under Chapter 4731. of the 156
Am. S. B. No. 152 Page 7
As Reported by the House Natural Resources Committee
Revised Code to practice medicine and surgery, osteopathic 157
medicine and surgery, or podiatric medicine and surgery; 158
(6) A physician assistant who holds a license to practice 159
as a physician assistant issued under Chapter 4730. of the 160
Revised Code, holds a valid prescriber number issued by the 161
state medical board, and has been granted physician-delegated 162
prescriptive authority; 163
(7) A veterinarian licensed under Chapter 4741. of the 164
Revised Code; 165
(8) A certified mental health assistant licensed under 166
Chapter 4772. of the Revised Code who has been granted 167
physician-delegated prescriptive authority by the physician 168
supervising the certified mental health assistant. 169
(J) "Sale" or "sell" includes any transaction made by any 170
person, whether as principal proprietor, agent, or employee, to 171
do or offer to do any of the following: deliver, distribute, 172
broker, exchange, gift or otherwise give away, or transfer, 173
whether the transfer is by passage of title, physical movement, 174
or both. 175
(K) "Wholesale sale" and "sale at wholesale" mean any sale 176
in which the purpose of the purchaser is to resell the article 177
purchased or received by the purchaser. 178
(L) "Retail sale" and "sale at retail" mean any sale other 179
than a wholesale sale or sale at wholesale. 180
(M) "Retail seller" means any person that sells any 181
dangerous drug to consumers without assuming control over and 182
responsibility for its administration. Mere advice or 183
instructions regarding administration do not constitute control 184
or establish responsibility. 185
Am. S. B. No. 152 Page 8
As Reported by the House Natural Resources Committee
(N) "Price information" means the price charged for a 186
prescription for a particular drug product and, in an easily 187
understandable manner, all of the following: 188
(1) The proprietary name of the drug product; 189
(2) The established (generic) name of the drug product; 190
(3) The strength of the drug product if the product 191
contains a single active ingredient or if the drug product 192
contains more than one active ingredient and a relevant strength 193
can be associated with the product without indicating each 194
active ingredient. The established name and quantity of each 195
active ingredient are required if such a relevant strength 196
cannot be so associated with a drug product containing more than 197
one ingredient. 198
(4) The dosage form; 199
(5) The price charged for a specific quantity of the drug 200
product. The stated price shall include all charges to the 201
consumer, including, but not limited to, the cost of the drug 202
product, professional fees, handling fees, if any, and a 203
statement identifying professional services routinely furnished 204
by the pharmacy. Any mailing fees and delivery fees may be 205
stated separately without repetition. The information shall not 206
be false or misleading. 207
(O) "Wholesale distributor of dangerous drugs" or 208
"wholesale distributor" means a person engaged in the sale of 209
dangerous drugs at wholesale and includes any agent or employee 210
of such a person authorized by the person to engage in the sale 211
of dangerous drugs at wholesale. 212
(P) "Manufacturer of dangerous drugs" or "manufacturer" 213
means a person, other than a pharmacist or prescriber, who 214
Am. S. B. No. 152 Page 9
As Reported by the House Natural Resources Committee
manufactures dangerous drugs and who is engaged in the sale of 215
those dangerous drugs. 216
(Q) "Terminal distributor of dangerous drugs" or "terminal 217
distributor" means a person who is engaged in the sale of 218
dangerous drugs at retail, or any person, other than a 219
manufacturer, repackager, outsourcing facility, third-party 220
logistics provider, wholesale distributor, or pharmacist, who 221
has possession, custody, or control of dangerous drugs for any 222
purpose other than for that person's own use and consumption. 223
"Terminal distributor" includes pharmacies, hospitals, nursing 224
homes, and laboratories and all other persons who procure 225
dangerous drugs for sale or other distribution by or under the 226
supervision of a pharmacist, licensed health professional 227
authorized to prescribe drugs, or other person authorized by the 228
state board of pharmacy. 229
(R) "Promote to the public" means disseminating a 230
representation to the public in any manner or by any means, 231
other than by labeling, for the purpose of inducing, or that is 232
likely to induce, directly or indirectly, the purchase of a 233
dangerous drug at retail. 234
(S) "Person" includes any individual, partnership, 235
association, limited liability company, or corporation, the 236
state, any political subdivision of the state, and any district, 237
department, or agency of the state or its political 238
subdivisions. 239
(T)(1) "Animal shelter" means a facility operated by a 240
humane society or any society organized under Chapter 1717. of 241
the Revised Code or a dog pound operated pursuant to Chapter 242

Section 15:
955. of the Revised Code. 243
Am. S. B. No. 152 Page 10
As Reported by the House Natural Resources Committee
(2) "County dog warden" means a dog warden or deputy dog 244
warden appointed or employed under section 955.12 of the Revised 245
Code. 246
(3) "Wild animal rehabilitation facility" means a facility 247
that holds a permit issued by the chief of the division of 248
wildlife for rehabilitation purposes in accordance with section 249

Section 16:
1533.08 of the Revised Code or rules adopted by the chief. 250
(U) "Food" has the same meaning as in section 3715.01 of 251
the Revised Code. 252
(V) "Pain management clinic" has the same meaning as in 253

Section 17:
section 4731.054 of the Revised Code. 254
(W) "Investigational drug or product" means a drug or 255
product that has successfully completed phase one of the United 256
States food and drug administration clinical trials and remains 257
under clinical trial, but has not been approved for general use 258
by the United States food and drug administration. 259
"Investigational drug or product" does not include controlled 260
substances in schedule I, as defined in section 3719.01 of the 261
Revised Code. 262
(X) "Product," when used in reference to an 263
investigational drug or product, means a biological product, 264
other than a drug, that is made from a natural human, animal, or 265
microorganism source and is intended to treat a disease or 266
medical condition. 267
(Y) "Third-party logistics provider" means a person that 268
provides or coordinates warehousing or other logistics services 269
pertaining to dangerous drugs including distribution, on behalf 270
of a manufacturer, wholesale distributor, or terminal 271
distributor of dangerous drugs, but does not take ownership of 272
Am. S. B. No. 152 Page 11
As Reported by the House Natural Resources Committee
the drugs or have responsibility to direct the sale or 273
disposition of the drugs. 274
(Z) "Repackager of dangerous drugs" or "repackager" means 275
a person that repacks and relabels dangerous drugs for sale or 276
distribution. 277
(AA) "Outsourcing facility" means a facility that is 278
engaged in the compounding and sale of sterile drugs and is 279
registered as an outsourcing facility with the United States 280
food and drug administration. 281
(BB) "Laboratory" means a laboratory licensed under this 282
chapter as a terminal distributor of dangerous drugs and 283
entrusted to have custody of any of the following drugs and to 284
use the drugs for scientific and clinical purposes and for 285
purposes of instruction: dangerous drugs that are not controlled 286
substances, as defined in section 3719.01 of the Revised Code; 287
dangerous drugs that are controlled substances, as defined in 288
that section; and controlled substances in schedule I, as 289
defined in that section. 290
(CC) "Overdose reversal drug" means both of the following: 291
(1) Naloxone; 292
(2) Any other drug that the state board of pharmacy, 293
through rules adopted in accordance with Chapter 119. of the 294
Revised Code, designates as a drug that is approved by the 295
federal food and drug administration for the reversal of a known 296
or suspected opioid-related overdose. 297
Sec. 4729.36. (A) No place except a pharmacy licensed as a 298
terminal distributor of dangerous drugs and no person except a 299
licensed pharmacist shall knowingly display any sign or 300
advertise in any fashion, using the words "pharmacy," "drugs," 301
Am. S. B. No. 152 Page 12
As Reported by the House Natural Resources Committee
"drug store," "drug store supplies," "pharmacist," "druggist," 302
"pharmaceutical chemist," "apothecary," "drug sundries," or 303
"medicine," or knowingly use any of these words or their 304
equivalent, of those word s in any manner that would lead or ten d 305
to lead the public to believe that the place is a pharmacy or 306
the person is a pharmacist. 307
(B) A pharmacy making retail sales may advertise by name 308
or therapeutic class the availability for sale or dispensing of 309
any dangerous drug provided that the advertising includes the 310
price information specified in the definition of that term in 311

Section 18:
section 4729.01 of the Revised Code. 312
Sec. 4729.531. (A) The state board of pharmacy may issue a 313
limited license to an animal shelter, a wild animal 314
rehabilitation facility, or county dog warden solely for the 315
purpose of purchasing, possessing, and administering drugs that 316
are distributed in a manufactured dosage form as described in 317

Section 19:
section 4729.532 of the Revised Code. Unless otherwise approved 318
by the board, no such license shall authorize or permit the 319
distribution of these drugs to any person other than the 320
originating wholesale distributor of the drugs. An application 321
for licensure shall include the information the board requires 322
by rule under this section. If the application meets the 323
requirements of the rules adopted under this section, the board 324
shall issue the license. 325
(B) The board, in accordance with Chapter 119. of the 326
Revised Code, shall adopt any rules necessary to administer and 327
enforce this section. The rules shall do all of the following: 328
(1) Require as a condition of licensure that an agent or 329
employee of an animal shelter or wild animal rehabilitation 330
facility or an agent or employee of a county dog warden, other 331
Am. S. B. No. 152 Page 13
As Reported by the House Natural Resources Committee
than a registered veterinary technician as defined in section 332

Section 20:
4741.01 of the Revised Code, has successfully completed a 333
euthanasia technician certification course described in section 334

Section 21:
4729.532 of the Revised Code; 335
(2) Specify the information the animal shelter, wild 336
animal rehabilitation facility, or county dog warden must 337
provide the board for issuance or renewal of a license; 338
(3) Address any other matters the board considers 339
necessary or appropriate for the administration and enforcement 340
of this section. 341
Sec. 4729.532. (A) No agent or employee of an animal 342
shelter, no agent or employee of a wild animal rehabilitation 343
facility, and no county dog warden or agent or employee of a 344
county dog warden shall perform euthanasia by means of lethal 345
injection on an animal by use of any substance other than a 346
substance in a manufactured dosage form that the state 347
veterinary medical licensing board, in consultation with the 348
state board of pharmacy, approves by rule adopted in accordance 349
with Chapter 119. of the Revised Code. 350
The agent or employee of an animal shelter or wild animal 351
rehabilitation facility, county dog warden, or agent or employee 352
of a county dog warden when using a lethal solution to perform 353
euthanasia on an animal shall use the solution in accordance 354
with the following methods: 355
(1) Intravenous injection by hypodermic needle; 356
(2) Intraperitoneal injection by hypodermic needle; 357
(3) Intracardial injection by hypodermic needle, but only 358
on an animal verified to be unconscious; 359
Am. S. B. No. 152 Page 14
As Reported by the House Natural Resources Committee
(4) Oral administration of solution or powder. 360
(B) Before euthanasia, a euthanasia technician may 361
administer a solution of one or more drugs exclusively for the 362
purpose of inducing anesthesia, sedation, or unconsciousness 363
prior to euthanasia. Only those drugs that have been approved by 364
rule adopted in accordance with Chapter 119. of the Revised Code 365
by the state board of pharmacy, in consultation with the state 366
veterinary medical licensing board, may be used. 367
(C) No agent or employee of an animal shelter or wild 368
animal rehabilitation facility and no county dog warden or agent 369
or employee of a county dog warden, other than a registered 370
veterinary technician as defined in section 4741.01 of the 371
Revised Code, shall perform euthanasia by means of lethal 372
injection on an animal or administer pre-euthanasia drugs that 373
induce anesthesia, sedation, or unconsciousness unless the agent 374
or employee or county dog warden has received certification 375
after successfully completing a euthanasia technician 376
certification course as described in this division. 377
The curriculum for a euthanasia technician certification 378
course shall be one that has been approved by the state 379
veterinary medical licensing board, shall be at least sixteen 380
hours in length, and shall include information in at least all 381
of the following areas: 382
(1) The pharmacology, proper administration, and storage 383
of euthanasia, sedation, and anesthesia solutions; 384
(2) Federal and state laws regulating the storage and 385
accountability of euthanasia, sedation, and anesthesia 386
solutions; 387
(3) Euthanasia technician stress management; 388
Am. S. B. No. 152 Page 15
As Reported by the House Natural Resources Committee
(4) Proper disposal of euthanized animals. 389
(D)(1) No agent or employee of an animal shelter or wild 390
animal rehabilitation facility shall perform euthanasia by means 391
of lethal injection on animals or administer pre-euthanasia 392
drugs that induce anesthesia, sedation, or unconsciousness under 393
this section unless the facility in which the agent or employee 394
works or is employed is licensed with the state board of 395
pharmacy under section 4729.531 of the Revised Code. No agent or 396
employee of a county dog warden shall perform euthanasia by 397
means of lethal injection on animals or administer pre- 398
euthanasia drugs that induce anesthesia, sedation, or 399
unconsciousness under this section unless the county dog warden 400
is licensed under section 4729.531 of the Revised Code. 401
(2) Any agent or employee of an animal shelter or wild 402
animal rehabilitation facility or county dog warden performing 403
euthanasia by means of lethal injection or administering pre- 404
euthanasia drugs that induce anesthesia, sedation, or 405
unconsciousness shall do so only in a humane and proficient 406
manner that is in conformity with the methods described in 407
divisions (A) and (B) of this section and not in violation of 408
Chapter 959. of the Revised Code. 409
(E) Nothing in this section precludes a licensed 410
veterinarian or registered veterinary technician as defined in 411

Section 22:
section 4741.01 of the Revised Code from engaging in the 412
practice of veterinary medicine as authorized in Chapter 4741. 413
of the Revised Code. 414
Sec. 4729.54. (A) As used in this section: 415
(1) "Category II" means any dangerous drug that is not 416
included in category III. 417
Am. S. B. No. 152 Page 16
As Reported by the House Natural Resources Committee
(2) "Category III" means any controlled substance that is 418
contained in schedule I, II, III, IV, or V. 419
(3) "Emergency medical service organization" has the same 420
meaning as in section 4765.01 of the Revised Code. 421
(4) "Emergency medical service organization satellite" 422
means a location where dangerous drugs are stored that is 423
separate from, but associated with, the headquarters of an 424
emergency medical service organization. "Emergency medical 425
service organization satellite" does not include the units under 426
the control of the emergency medical service organization. 427
(5) "Person" includes an emergency medical service 428
organization or an emergency medical service organization 429
satellite. 430
(6) "Schedule I," "schedule II," "schedule III," "schedule 431
IV," and "schedule V" have the same meanings as in section 432

Section 23:
3719.01 of the Revised Code. 433
(B)(1) A person seeking to be licensed as a terminal 434
distributor of dangerous drugs shall file with the executive 435
director of the state board of pharmacy a verified application. 436
After it is filed, the application may not be withdrawn without 437
approval of the board. 438
(2) An application shall contain all the following that 439
apply in the applicant's case: 440
(a) Information that the board requires relative to the 441
qualifications of a terminal distributor of dangerous drugs set 442
forth in section 4729.55 of the Revised Code; 443
(b) A statement as to whether the person is seeking to be 444
licensed as a category II, category III, limited category II, or 445
Am. S. B. No. 152 Page 17
As Reported by the House Natural Resources Committee
limited category III terminal distributor of dangerous drugs; 446
(c) If the person is seeking to be licensed as a limited 447
category II or limited category III terminal distributor of 448
dangerous drugs, a list of the dangerous drugs that the person 449
is seeking to possess, have custody or control of, and 450
distribute, which list shall also specify the purpose for which 451
those drugs will be used and their source; 452
(d) If the person is an emergency medical service 453
organization, the information that is specified in divisions (C) 454
(1) and (2) of this section, and if the person is an emergency 455
medical service organization satellite, the information required 456
under division (D) of this section; 457
(e) Except with respect to the units under the control of 458
an emergency medical service organization, the identity of the 459
one establishment or place at which the person intends to engage 460
in the sale or other distribution of dangerous drugs at retail, 461
and maintain possession, custody, or control of dangerous drugs 462
for purposes other than the person's own use or consumption; 463
(f) If the application pertains to a pain management 464
clinic, information that demonstrates, to the satisfaction of 465
the board, compliance with division (A) of section 4729.552 of 466
the Revised Code. 467
(C)(1) Each emergency medical service organization that 468
applies for a terminal distributor of dangerous drugs license 469
shall submit with its application all of the following: 470
(a) A copy of its standing orders or protocol, which 471
orders or protocol shall be signed by a physician; 472
(b) A list of the dangerous drugs that the units under its 473
control may carry, expressed in standard dose units, which shall 474
Am. S. B. No. 152 Page 18
As Reported by the House Natural Resources Committee
be signed by a physician; 475
(c) A list of the personnel employed or used by the 476
organization to provide emergency medical services in accordance 477
with Chapter 4765. of the Revised Code. 478
In accordance with Chapter 119. of the Revised Code, the 479
board shall adopt rules specifying when an emergency medical 480
service organization that is licensed as a terminal distributor 481
must notify the board of any changes in its documentation 482
submitted pursuant to division (C)(1) of this section. 483
(2) An emergency medical service organization seeking to 484
be licensed as a terminal distributor of dangerous drugs shall 485
list in its application for licensure the following additional 486
information: 487
(a) The units under its control that the organization 488
determines will possess dangerous drugs for the purpose of 489
administering emergency medical services in accordance with 490
Chapter 4765. of the Revised Code; 491
(b) With respect to each such unit, whether the dangerous 492
drugs that the organization determines the unit will possess are 493
in category II or III. 494
(3) An emergency medical service organization that is 495
licensed as a terminal distributor of dangerous drugs shall file 496
a new application for such licensure if there is any change in 497
the number or location of any of its units or if there is any 498
change in the category of the dangerous drugs that any unit will 499
possess. 500
(4) A unit listed in an application for licensure pursuant 501
to division (C)(2) of this section may obtain the dangerous 502
drugs it is authorized to possess from its emergency medical 503
Am. S. B. No. 152 Page 19
As Reported by the House Natural Resources Committee
service organization or, on a replacement basis, from a hospital 504
pharmacy. If units will obtain dangerous drugs from a hospital 505
pharmacy, the organization shall file, and maintain in current 506
form, the following items with the pharmacist who is responsible 507
for the hospital's terminal distributor of dangerous drugs 508
license: 509
(a) A copy of its standing orders or protocol; 510
(b) A list of the personnel employed or used by the 511
organization to provide emergency medical services in accordance 512
with Chapter 4765. of the Revised Code, who are authorized to 513
possess the drugs, which list also shall indicate the personnel 514
who are authorized to administer the drugs. 515
(D) Each emergency medical service organization satellite 516
that applies for a terminal distributor of dangerous drugs 517
license shall submit with its application all of the information 518
that the board requires to be submitted with the application, as 519
specified in rules the board shall adopt in accordance with 520
Chapter 119. of the Revised Code. 521
(E) There shall be four categories of terminal distributor 522
of dangerous drugs licenses. The categories are as follows: 523
(1) Category II license. A person who obtains this license 524
may possess, have custody or control of, and distribute only the 525
dangerous drugs described in category II. 526
(2) Limited category II license. A person who obtains this 527
license may possess, have custody or control of, and distribute 528
only the dangerous drugs described in category II that were 529
listed in the application for licensure. 530
(3) Category III license, which may include a pain 531
management clinic classification issued under section 4729.552 532
Am. S. B. No. 152 Page 20
As Reported by the House Natural Resources Committee
of the Revised Code. A person who obtains this license may 533
possess, have custody or control of, and distribute the 534
dangerous drugs described in category II and category III. If 535
the license includes a pain management clinic classification, 536
the person may operate a pain management clinic. 537
(4) Limited category III license. A person who obtains 538
this license may possess, have custody or control of, and 539
distribute only the dangerous drugs described in category II or 540
category III that were listed in the application for licensure. 541
(F) Except for an application made by a county dog warden 542
or on behalf of an animal shelter or wild animal rehabilitation 543
facility, if an applicant for a limited category II license or 544
limited category III license intends to administer dangerous 545
drugs to a person or animal, the applicant shall submit, with 546
the application, a copy of its protocol or standing orders. The 547
protocol or orders shall be signed by a licensed health 548
professional authorized to prescribe drugs, specify the 549
dangerous drugs to be administered, and list personnel who are 550
authorized to administer the dangerous drugs in accordance with 551
federal law or the law of this state. 552
An application made by a county dog warden or on behalf of 553
an animal shelter or wild animal rehabilitation facility shall 554
include a list of the dangerous drugs to be administered to 555
animals and the personnel who are authorized to administer the 556
drugs to animals in accordance with section 4729.532 of the 557
Revised Code. 558
In accordance with Chapter 119. of the Revised Code, the 559
board shall adopt rules specifying when a licensee must notify 560
the board of any changes in its documentation submitted pursuant 561
to this division. 562
Am. S. B. No. 152 Page 21
As Reported by the House Natural Resources Committee
(G)(1) Except as provided in division (G)(3) of this 563

Section 24:
section, each applicant for licensure as a terminal distributor 564
of dangerous drugs shall submit, with the application, a license 565
fee. The amount assessed shall not be returned to the applicant 566
if the applicant fails to qualify for the license. 567
(2) The following fees apply under division (G)(1) of this 568

Section 25:
section: 569
(a) Except as provided in division (G)(2)(b) of this 570

Section 26:
section: 571
(i) Three hundred twenty dollars for a category II or 572
limited category II license; 573
(ii) Four hundred forty dollars for a category III 574
license, including a license with a pain management clinic 575
classification issued under section 4729.552 of the Revised 576
Code, or a limited category III license. 577
(b) One hundred twenty dollars for all of the following: 578
(i) A person who is required to hold a license as a 579
terminal distributor of dangerous drugs pursuant to division (C) 580
of section 4729.541 of the Revised Code; 581
(ii) A professional association, corporation, partnership, 582
or limited liability company organized for the purpose of 583
practicing veterinary medicine that is not included in division 584
(G)(2)(b)(i) of this section; 585
(iii) An emergency medical service organization satellite. 586
(3) No fee applies for a license issued to a charitable 587
pharmacy, as defined in section 3719.811 of the Revised Code, if 588
the charitable pharmacy is participating in the drug repository 589
program established under section 3715.87 of the Revised Code. 590
Am. S. B. No. 152 Page 22
As Reported by the House Natural Resources Committee
(H)(1) The board shall issue a terminal distributor of 591
dangerous drugs license to each person who submits an 592
application for such licensure in accordance with this section, 593
pays the required license fee, is determined by the board to 594
meet the requirements set forth in section 4729.55 of the 595
Revised Code, and satisfies any other applicable requirements of 596
this section. 597
(2) Except for the license of a county dog warden, the 598
license shall describe the one establishment or place at which 599
the licensee may engage in the sale or other distribution of 600
dangerous drugs at retail and maintain possession, custody, or 601
control of dangerous drugs for purposes other than the 602
licensee's own use or consumption. The one establishment or 603
place shall be that which is identified in the application for 604
licensure. 605
No such license shall authorize or permit the terminal 606
distributor of dangerous drugs named in it to engage in the sale 607
or other distribution of dangerous drugs at retail or to 608
maintain possession, custody, or control of dangerous drugs for 609
any purpose other than the distributor's own use or consumption, 610
at any establishment or place other than that described in the 611
license, except that an agent or employee of an animal shelter 612
or wild animal rehabilitation facility or county dog warden may 613
possess and use dangerous drugs in the course of business as 614
provided in section 4729.532 of the Revised Code. 615
(3) The license of an emergency medical service 616
organization shall cover the organization's headquarters and, in 617
addition, shall cover and describe all the units of the 618
organization listed in its application for licensure. 619
(I)(1) All licenses issued or renewed pursuant to this 620
Am. S. B. No. 152 Page 23
As Reported by the House Natural Resources Committee

Section 27:
section shall be effective for a period specified by the board 621
in rules adopted under section 4729.26 of the Revised Code. The 622
effective period for an initial or renewed license shall not 623
exceed twenty-four months unless the board extends the period in 624
rules to adjust license renewal schedules. A license shall be 625
renewed by the board according to the provisions of this 626

Section 28:
section, the standard renewal procedure of Chapter 4745. of the 627
Revised Code, and rules adopted by the board under section 628

Section 29:
4729.26 of the Revised Code. A person seeking to renew a license 629
shall submit an application for renewal and pay the required fee 630
on or before the date specified in the rules adopted by the 631
board. The fee required for the renewal of a license shall be 632
the same as the license fee that applies under division (G)(2) 633
of this section. 634
(2)(a) Subject to division (I)(2)(b) of this section, a 635
license that has not been renewed by the date specified in rules 636
adopted by the board may be reinstated only upon payment of the 637
required renewal fee and a penalty fee of one hundred ten 638
dollars. 639
(b) If an application for renewal has not been submitted 640
by the sixty-first day after the renewal date specified in rules 641
adopted by the board, the license is considered void and cannot 642
be renewed, but the license holder may reapply for licensure. 643
(3) A terminal distributor of dangerous drugs that fails 644
to renew licensure in accordance with this section and rules 645
adopted by the board is prohibited from engaging in the retail 646
sale, possession, or distribution of dangerous drugs until a 647
valid license is issued by the board. 648
(J)(1) No emergency medical service organization that is 649
licensed as a terminal distributor of dangerous drugs shall fail 650
Am. S. B. No. 152 Page 24
As Reported by the House Natural Resources Committee
to comply with division (C)(1), (3), or (4) of this section. 651
(2) No licensed terminal distributor of dangerous drugs 652
shall possess, have custody or control of, or distribute 653
dangerous drugs that the terminal distributor is not entitled to 654
possess, have custody or control of, or distribute by virtue of 655
its category of licensure. 656
(3) No licensee that is required by division (F) of this 657

Section 30:
section to notify the board of changes in its protocol or 658
standing orders, or in personnel, shall fail to comply with that 659
division. 660
(K) The board may enter into agreements with other states, 661
federal agencies, and other entities to exchange information 662
concerning licensing and inspection of terminal distributors of 663
dangerous drugs located within or outside this state and to 664
investigate alleged violations of the laws and rules governing 665
distribution of drugs by terminal distributors. Any information 666
received pursuant to such an agreement is subject to the same 667
confidentiality requirements applicable to the agency or entity 668
from which it was received and shall not be released without 669
prior authorization from that agency or entity. 670
Sec. 4729.55. No license shall be issued to an applicant 671
for licensure as a terminal distributor of dangerous drugs 672
unless the applicant has furnished satisfactory proof to the 673
state board of pharmacy that: 674
(A) The applicant is equipped as to land, buildings, and 675
equipment to properly carry on the business of a terminal 676
distributor of dangerous drugs within the category of licensure 677
approved by the board. 678
(B) One of the following will maintain supervision and 679
Am. S. B. No. 152 Page 25
As Reported by the House Natural Resources Committee
control over the possession and custody of dangerous drugs and 680
controlled substances that may be acquired by or on behalf of 681
the applicant: 682
(1) A pharmacist, licensed health professional authorized 683
to prescribe drugs, or other person authorized by the board,; 684
(2) An animal shelter, wild animal rehabilitation 685
facility, or county dog warden licensed under section 4729.531 686
of the Revised Code, or ; 687
(3) A laboratory will maintain supervision and control 688
over the possession and custody of dangerous drugs and 689
controlled substances that may be acquired by or on behalf of 690
the applicant. 691
(C) Adequate safeguards are assured to prevent the sale or 692
other distribution of dangerous drugs by any person other than a 693
pharmacist or licensed health professional authorized to 694
prescribe drugs. 695
(D) Adequate safeguards are assured that the applicant 696
will carry on the business of a terminal distributor of 697
dangerous drugs in a manner that allows pharmacists and pharmacy 698
interns employed by the terminal distributor to practice 699
pharmacy in a safe and effective manner. 700
(E) If the applicant, or any agent or employee of the 701
applicant, has been found guilty of violating section 4729.51 of 702
the Revised Code, the "Federal Food, Drug, and Cosmetic Act," 52 703
Stat. 1040 (1938), 21 U.S.C.A. 301, the federal drug abuse 704
control laws, Chapter 2925., 3715., 3719., or 4729. of the 705
Revised Code, or any rule of the board, adequate safeguards are 706
assured to prevent the recurrence of the violation. 707
(F) If the application is made on behalf of an animal 708
Am. S. B. No. 152 Page 26
As Reported by the House Natural Resources Committee
shelter, wild animal rehabilitation facility, or county dog 709
warden, at least one of the agents or employees of the animal 710
shelter or county dog warden is certified in compliance with 711

Section 31:
section 4729.532 of the Revised Code. 712
(G) In the case of an applicant who is a retail seller of 713
peritoneal dialysis solutions in original packages labeled as 714
required by the "Federal Food, Drug, and Cosmetic Act," 52 Stat. 715
1040 (1938), 21 U.S.C.A. 301, the applicant will maintain 716
supervision and control over the possession, custody, and retail 717
sale of the peritoneal dialysis solutions. 718
(H) In the case of an applicant who is a pain management 719
clinic, the applicant meets the requirements to receive a 720
license with a pain management clinic classification issued 721
under section 4729.552 of the Revised Code. 722

Section 32:
Section 2. That existing sections 4729.01, 4729.36, 723

Section 33:
4729.531, 4729.532, 4729.54, and 4729.55 of the Revised Code are 724
hereby repealed. 725
[DELETED: nA      .  :1 1 1 1 1 1 1 1]
[DELETED: 2  1 1 2 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4]
[DELETED: 2  4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 6 6 6 6 6 6 6 6 6 7 7 7]
[DELETED: 2  7 7 7 7 7 7 7 8 8 8 8 8 8 8 8 8 8 9 9 9 9 9 9 9 9 9 9]
[DELETED: 2  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]
[DELETED: 2  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]
[DELETED: 2  1 1 1 1 1 1 1 1;1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]
[DELETED: 2  1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2]
[DELETED: 2  2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2]
[DELETED: 2  2 2 2 2 2 2.2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2]
[DELETED: 2  2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2:2;2 2 2 2 2.2 2 2 3 3]
[DELETED: 2  3 3 3 3 3.3 3 3 3 3.3 3 3 3 3 3 3 3 3 3 3 3 3.3 3 3:3 3 3 3]
[DELETED: 2  3 3 3;3 3 3;3 3 3.3 3 3 3 3 3 3 3 3.3 3 3 3 3:3;3;3 3;3]
[DELETED: 2 .3 3 3 3 3 3 3.3 3 3 3 3 3 3 3 3 3.3 3 3 3 3:3 3;3 3 3;3;3]
[DELETED: 2 .3 3 3 3 3 3 3 3 3-3 3 4.4 4 4-4 4 4 4 4.4 4 4 4 4.4 4 4 4]
[DELETED: 2  4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4]
[DELETED: 2  4 4 4 4 4 4 4 4)4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4]
[DELETED: 2  4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 5 5 5 5]
[DELETED: 2  5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5]
[DELETED: 2  5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5]
[DELETED: 2  5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5]
[DELETED: 2  5 5 5 5 5 5 5 5 5 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6]
[DELETED: 2  6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6]
[DELETED: 2  6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6.6 6 6 6 6 6 6 6 6 6]
[DELETED: 2  6 6:6 6;6 6 6;6 6 6 6 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7]
[DELETED: 2  7 7 7 7 7 7 7 7 7 7 7 7 7.7 7 7.7]


================================================================================

Raw Text:
As Reported by the House Natural Resources Committee
136th General Assembly
Regular Session Am. S. B. No. 152
2025-2026
Senator Brenner
Cosponsors: Senators Lang, Cirino, DeMora, Hicks-Hudson, Liston, Patton,
Reineke, Roegner
Representative Mathews, T.
To amend sections 4729.01, 4729.36, 4729.531, 1
4729.532, 4729.54, and 4729.55 of the Revised 2
Code to allow wild animal rehabilitation 3
facilities to receive a limited license to 4
administer euthanasia drugs and to modify the 5
law regarding the use of terms that are limited 6
to pharmacies and pharmacists. 7
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:
Section 1. That sections 4729.01, 4729.36, 4729.531, 8
4729.532, 4729.54, and 4729.55 of the Revised Code be amended to 9
read as follows: 10
Sec. 4729.01. As used in this chapter: 11
(A) "Pharmacy," except when used in a context that refers 12
to the practice of pharmacy, means any area, room, rooms, place 13
of business, department, or portion of any of the foregoing 14
where the practice of pharmacy is conducted. 15
(B) "Practice of pharmacy" means providing pharmacist care 16
requiring specialized knowledge, judgment, and skill derived 17

Am. S. B. No. 152 Page 2
As Reported by the House Natural Resources Committee
from the principles of biological, chemical, behavioral, social, 18
pharmaceutical, and clinical sciences. As used in this division, 19
"pharmacist care" includes the following: 20
(1) Interpreting prescriptions; 21
(2) Dispensing drugs and drug therapy related devices; 22
(3) Compounding drugs; 23
(4) Counseling individuals with regard to their drug 24
therapy, recommending drug therapy related devices, and 25
assisting in the selection of drugs and appliances for treatment 26
of common diseases and injuries and providing instruction in the 27
proper use of the drugs and appliances; 28
(5) Performing drug regimen reviews with individuals by 29
discussing all of the drugs that the individual is taking and 30
explaining the interactions of the drugs; 31
(6) Performing drug utilization reviews with licensed 32
health professionals authorized to prescribe drugs when the 33
pharmacist determines that an individual with a prescription has 34
a drug regimen that warrants additional discussion with the 35
prescriber; 36
(7) Advising an individual and the health care 37
professionals treating an individual with regard to the 38
individual's drug therapy; 39
(8) Acting pursuant to a consult agreement, if an 40
agreement has been established; 41
(9) Engaging in the administration of immunizations to the 42
extent authorized by section 4729.41 of the Revised Code; 43
(10) Engaging in the administration of drugs to the extent 44

Am. S. B. No. 152 Page 3
As Reported by the House Natural Resources Committee
authorized by section 4729.45 of the Revised Code. 45
(C) "Compounding" means the preparation, mixing, 46
assembling, packaging, and labeling of one or more drugs in any 47
of the following circumstances: 48
(1) Pursuant to a prescription issued by a licensed health 49
professional authorized to prescribe drugs; 50
(2) Pursuant to the modification of a prescription made in 51
accordance with a consult agreement; 52
(3) As an incident to research, teaching activities, or 53
chemical analysis; 54
(4) In anticipation of orders for drugs pursuant to 55
prescriptions, based on routine, regularly observed dispensing 56
patterns; 57
(5) Pursuant to a request made by a licensed health 58
professional authorized to prescribe drugs for a drug that is to 59
be used by the professional for the purpose of direct 60
administration to patients in the course of the professional's 61
practice, if all of the following apply: 62
(a) At the time the request is made, the drug is not 63
commercially available regardless of the reason that the drug is 64
not available, including the absence of a manufacturer for the 65
drug or the lack of a readily available supply of the drug from 66
a manufacturer. 67
(b) A limited quantity of the drug is compounded and 68
provided to the professional. 69
(c) The drug is compounded and provided to the 70
professional as an occasional exception to the normal practice 71
of dispensing drugs pursuant to patient-specific prescriptions. 72

Am. S. B. No. 152 Page 4
As Reported by the House Natural Resources Committee
(D) "Consult agreement" means an agreement that has been 73
entered into under section 4729.39 of the Revised Code. 74
(E) "Drug" means: 75
(1) Any article recognized in the United States 76
pharmacopoeia and national formulary, or any supplement to them, 77
intended for use in the diagnosis, cure, mitigation, treatment, 78
or prevention of disease in humans or animals; 79
(2) Any other article intended for use in the diagnosis, 80
cure, mitigation, treatment, or prevention of disease in humans 81
or animals; 82
(3) Any article, other than food, intended to affect the 83
structure or any function of the body of humans or animals; 84
(4) Any article intended for use as a component of any 85
article specified in division (E)(1), (2), or (3) of this 86
section; but does not include devices or their components, 87
parts, or accessories. 88
"Drug" does not include "hemp" or a "hemp product" as 89
those terms are defined in section 928.01 of the Revised Code. 90
(F) "Dangerous drug" means any of the following: 91
(1) Any drug to which either of the following applies: 92
(a) Under the "Federal Food, Drug, and Cosmetic Act," 52 93
Stat. 1040 (1938), 21 U.S.C.A. 301, as amended, the drug is 94
required to bear a label containing the legend "Caution: Federal 95
law prohibits dispensing without prescription" or "Caution: 96
Federal law restricts this drug to use by or on the order of a 97
licensed veterinarian" or any similar restrictive statement, or 98
the drug may be dispensed only upon a prescription; 99

Am. S. B. No. 152 Page 5
As Reported by the House Natural Resources Committee
(b) Under Chapter 3715. or 3719. of the Revised Code, the 100
drug may be dispensed only upon a prescription. 101
(2) Any drug that contains a schedule V controlled 102
substance and that is exempt from Chapter 3719. of the Revised 103
Code or to which that chapter does not apply; 104
(3) Any drug intended for administration by injection into 105
the human body other than through a natural orifice of the human 106
body; 107
(4) Any drug that is a biological product, as defined in 108
section 3715.01 of the Revised Code. 109
(G) "Federal drug abuse control laws" has the same meaning 110
as in section 3719.01 of the Revised Code. 111
(H) "Prescription" means all of the following: 112
(1) A written, electronic, or oral order for drugs or 113
combinations or mixtures of drugs to be used by a particular 114
individual or for treating a particular animal, issued by a 115
licensed health professional authorized to prescribe drugs; 116
(2) For purposes of sections 4723.4810, 4729.282, 117
4730.432, and 4731.93 of the Revised Code, a written, 118
electronic, or oral order for a drug to treat chlamydia, 119
gonorrhea, or trichomoniasis issued to and in the name of a 120
patient who is not the intended user of the drug but is the 121
sexual partner of the intended user; 122
(3) For purposes of sections 3313.7110, 3313.7111, 123
3314.143, 3326.28, 3328.29, 4723.483, 4729.88, 4730.433, 124
4731.96, and 5101.76 of the Revised Code, a written, electronic, 125
or oral order for an epinephrine autoinjector issued to and in 126
the name of a school, school district, or camp; 127

Am. S. B. No. 152 Page 6
As Reported by the House Natural Resources Committee
(4) For purposes of Chapter 3728. and sections 4723.483, 128
4729.88, 4730.433, and 4731.96 of the Revised Code, a written, 129
electronic, or oral order for an epinephrine autoinjector issued 130
to and in the name of a qualified entity, as defined in section 131
3728.01 of the Revised Code; 132
(5) For purposes of sections 3313.7115, 3313.7116, 133
3314.147, 3326.60, 3328.38, 4723.4811, 4730.437, 4731.92, and 134
5101.78 of the Revised Code, a written, electronic, or oral 135
order for injectable or nasally administered glucagon in the 136
name of a school, school district, or camp. 137
(I) "Licensed health professional authorized to prescribe 138
drugs" or "prescriber" means an individual who is authorized by 139
law to prescribe drugs or dangerous drugs or drug therapy 140
related devices in the course of the individual's professional 141
practice, including only the following: 142
(1) A dentist licensed under Chapter 4715. of the Revised 143
Code; 144
(2) A clinical nurse specialist, certified nurse-midwife, 145
or certified nurse practitioner who holds a current, valid 146
license issued under Chapter 4723. of the Revised Code to 147
practice nursing as an advanced practice registered nurse; 148
(3) A certified registered nurse anesthetist who holds a 149
current, valid license issued under Chapter 4723. of the Revised 150
Code to practice nursing as an advanced practice registered 151
nurse, but only to the extent of the nurse's authority under 152
sections 4723.43 and 4723.434 of the Revised Code; 153
(4) An optometrist licensed under Chapter 4725. of the 154
Revised Code to practice optometry; 155
(5) A physician authorized under Chapter 4731. of the 156

Am. S. B. No. 152 Page 7
As Reported by the House Natural Resources Committee
Revised Code to practice medicine and surgery, osteopathic 157
medicine and surgery, or podiatric medicine and surgery; 158
(6) A physician assistant who holds a license to practice 159
as a physician assistant issued under Chapter 4730. of the 160
Revised Code, holds a valid prescriber number issued by the 161
state medical board, and has been granted physician-delegated 162
prescriptive authority; 163
(7) A veterinarian licensed under Chapter 4741. of the 164
Revised Code; 165
(8) A certified mental health assistant licensed under 166
Chapter 4772. of the Revised Code who has been granted 167
physician-delegated prescriptive authority by the physician 168
supervising the certified mental health assistant. 169
(J) "Sale" or "sell" includes any transaction made by any 170
person, whether as principal proprietor, agent, or employee, to 171
do or offer to do any of the following: deliver, distribute, 172
broker, exchange, gift or otherwise give away, or transfer, 173
whether the transfer is by passage of title, physical movement, 174
or both. 175
(K) "Wholesale sale" and "sale at wholesale" mean any sale 176
in which the purpose of the purchaser is to resell the article 177
purchased or received by the purchaser. 178
(L) "Retail sale" and "sale at retail" mean any sale other 179
than a wholesale sale or sale at wholesale. 180
(M) "Retail seller" means any person that sells any 181
dangerous drug to consumers without assuming control over and 182
responsibility for its administration. Mere advice or 183
instructions regarding administration do not constitute control 184
or establish responsibility. 185

Am. S. B. No. 152 Page 8
As Reported by the House Natural Resources Committee
(N) "Price information" means the price charged for a 186
prescription for a particular drug product and, in an easily 187
understandable manner, all of the following: 188
(1) The proprietary name of the drug product; 189
(2) The established (generic) name of the drug product; 190
(3) The strength of the drug product if the product 191
contains a single active ingredient or if the drug product 192
contains more than one active ingredient and a relevant strength 193
can be associated with the product without indicating each 194
active ingredient. The established name and quantity of each 195
active ingredient are required if such a relevant strength 196
cannot be so associated with a drug product containing more than 197
one ingredient. 198
(4) The dosage form; 199
(5) The price charged for a specific quantity of the drug 200
product. The stated price shall include all charges to the 201
consumer, including, but not limited to, the cost of the drug 202
product, professional fees, handling fees, if any, and a 203
statement identifying professional services routinely furnished 204
by the pharmacy. Any mailing fees and delivery fees may be 205
stated separately without repetition. The information shall not 206
be false or misleading. 207
(O) "Wholesale distributor of dangerous drugs" or 208
"wholesale distributor" means a person engaged in the sale of 209
dangerous drugs at wholesale and includes any agent or employee 210
of such a person authorized by the person to engage in the sale 211
of dangerous drugs at wholesale. 212
(P) "Manufacturer of dangerous drugs" or "manufacturer" 213
means a person, other than a pharmacist or prescriber, who 214

Am. S. B. No. 152 Page 9
As Reported by the House Natural Resources Committee
manufactures dangerous drugs and who is engaged in the sale of 215
those dangerous drugs. 216
(Q) "Terminal distributor of dangerous drugs" or "terminal 217
distributor" means a person who is engaged in the sale of 218
dangerous drugs at retail, or any person, other than a 219
manufacturer, repackager, outsourcing facility, third-party 220
logistics provider, wholesale distributor, or pharmacist, who 221
has possession, custody, or control of dangerous drugs for any 222
purpose other than for that person's own use and consumption. 223
"Terminal distributor" includes pharmacies, hospitals, nursing 224
homes, and laboratories and all other persons who procure 225
dangerous drugs for sale or other distribution by or under the 226
supervision of a pharmacist, licensed health professional 227
authorized to prescribe drugs, or other person authorized by the 228
state board of pharmacy. 229
(R) "Promote to the public" means disseminating a 230
representation to the public in any manner or by any means, 231
other than by labeling, for the purpose of inducing, or that is 232
likely to induce, directly or indirectly, the purchase of a 233
dangerous drug at retail. 234
(S) "Person" includes any individual, partnership, 235
association, limited liability company, or corporation, the 236
state, any political subdivision of the state, and any district, 237
department, or agency of the state or its political 238
subdivisions. 239
(T)(1) "Animal shelter" means a facility operated by a 240
humane society or any society organized under Chapter 1717. of 241
the Revised Code or a dog pound operated pursuant to Chapter 242
955. of the Revised Code. 243

Am. S. B. No. 152 Page 10
As Reported by the House Natural Resources Committee
(2) "County dog warden" means a dog warden or deputy dog 244
warden appointed or employed under section 955.12 of the Revised 245
Code. 246
(3) "Wild animal rehabilitation facility" means a facility 247
that holds a permit issued by the chief of the division of 248
wildlife for rehabilitation purposes in accordance with section 249
1533.08 of the Revised Code or rules adopted by the chief. 250
(U) "Food" has the same meaning as in section 3715.01 of 251
the Revised Code. 252
(V) "Pain management clinic" has the same meaning as in 253
section 4731.054 of the Revised Code. 254
(W) "Investigational drug or product" means a drug or 255
product that has successfully completed phase one of the United 256
States food and drug administration clinical trials and remains 257
under clinical trial, but has not been approved for general use 258
by the United States food and drug administration. 259
"Investigational drug or product" does not include controlled 260
substances in schedule I, as defined in section 3719.01 of the 261
Revised Code. 262
(X) "Product," when used in reference to an 263
investigational drug or product, means a biological product, 264
other than a drug, that is made from a natural human, animal, or 265
microorganism source and is intended to treat a disease or 266
medical condition. 267
(Y) "Third-party logistics provider" means a person that 268
provides or coordinates warehousing or other logistics services 269
pertaining to dangerous drugs including distribution, on behalf 270
of a manufacturer, wholesale distributor, or terminal 271
distributor of dangerous drugs, but does not take ownership of 272

Am. S. B. No. 152 Page 11
As Reported by the House Natural Resources Committee
the drugs or have responsibility to direct the sale or 273
disposition of the drugs. 274
(Z) "Repackager of dangerous drugs" or "repackager" means 275
a person that repacks and relabels dangerous drugs for sale or 276
distribution. 277
(AA) "Outsourcing facility" means a facility that is 278
engaged in the compounding and sale of sterile drugs and is 279
registered as an outsourcing facility with the United States 280
food and drug administration. 281
(BB) "Laboratory" means a laboratory licensed under this 282
chapter as a terminal distributor of dangerous drugs and 283
entrusted to have custody of any of the following drugs and to 284
use the drugs for scientific and clinical purposes and for 285
purposes of instruction: dangerous drugs that are not controlled 286
substances, as defined in section 3719.01 of the Revised Code; 287
dangerous drugs that are controlled substances, as defined in 288
that section; and controlled substances in schedule I, as 289
defined in that section. 290
(CC) "Overdose reversal drug" means both of the following: 291
(1) Naloxone; 292
(2) Any other drug that the state board of pharmacy, 293
through rules adopted in accordance with Chapter 119. of the 294
Revised Code, designates as a drug that is approved by the 295
federal food and drug administration for the reversal of a known 296
or suspected opioid-related overdose. 297
Sec. 4729.36. (A) No place except a pharmacy licensed as a 298
terminal distributor of dangerous drugs and no person except a 299
licensed pharmacist shall knowingly display any sign or 300
advertise in any fashion, using the words "pharmacy," "drugs," 301

Am. S. B. No. 152 Page 12
As Reported by the House Natural Resources Committee
"drug store," "drug store supplies," "pharmacist," "druggist," 302
"pharmaceutical chemist," "apothecary," "drug sundries," or 303
"medicine," or knowingly use any of these words or their 304
equivalent, of those word s in any manner that would lead or ten d 305
to lead the public to believe that the place is a pharmacy or 306
the person is a pharmacist. 307
(B) A pharmacy making retail sales may advertise by name 308
or therapeutic class the availability for sale or dispensing of 309
any dangerous drug provided that the advertising includes the 310
price information specified in the definition of that term in 311
section 4729.01 of the Revised Code. 312
Sec. 4729.531. (A) The state board of pharmacy may issue a 313
limited license to an animal shelter, a wild animal 314
rehabilitation facility, or county dog warden solely for the 315
purpose of purchasing, possessing, and administering drugs that 316
are distributed in a manufactured dosage form as described in 317
section 4729.532 of the Revised Code. Unless otherwise approved 318
by the board, no such license shall authorize or permit the 319
distribution of these drugs to any person other than the 320
originating wholesale distributor of the drugs. An application 321
for licensure shall include the information the board requires 322
by rule under this section. If the application meets the 323
requirements of the rules adopted under this section, the board 324
shall issue the license. 325
(B) The board, in accordance with Chapter 119. of the 326
Revised Code, shall adopt any rules necessary to administer and 327
enforce this section. The rules shall do all of the following: 328
(1) Require as a condition of licensure that an agent or 329
employee of an animal shelter or wild animal rehabilitation 330
facility or an agent or employee of a county dog warden, other 331

Am. S. B. No. 152 Page 13
As Reported by the House Natural Resources Committee
than a registered veterinary technician as defined in section 332
4741.01 of the Revised Code, has successfully completed a 333
euthanasia technician certification course described in section 334
4729.532 of the Revised Code; 335
(2) Specify the information the animal shelter, wild 336
animal rehabilitation facility, or county dog warden must 337
provide the board for issuance or renewal of a license; 338
(3) Address any other matters the board considers 339
necessary or appropriate for the administration and enforcement 340
of this section. 341
Sec. 4729.532. (A) No agent or employee of an animal 342
shelter, no agent or employee of a wild animal rehabilitation 343
facility, and no county dog warden or agent or employee of a 344
county dog warden shall perform euthanasia by means of lethal 345
injection on an animal by use of any substance other than a 346
substance in a manufactured dosage form that the state 347
veterinary medical licensing board, in consultation with the 348
state board of pharmacy, approves by rule adopted in accordance 349
with Chapter 119. of the Revised Code. 350
The agent or employee of an animal shelter or wild animal 351
rehabilitation facility, county dog warden, or agent or employee 352
of a county dog warden when using a lethal solution to perform 353
euthanasia on an animal shall use the solution in accordance 354
with the following methods: 355
(1) Intravenous injection by hypodermic needle; 356
(2) Intraperitoneal injection by hypodermic needle; 357
(3) Intracardial injection by hypodermic needle, but only 358
on an animal verified to be unconscious; 359

Am. S. B. No. 152 Page 14
As Reported by the House Natural Resources Committee
(4) Oral administration of solution or powder. 360
(B) Before euthanasia, a euthanasia technician may 361
administer a solution of one or more drugs exclusively for the 362
purpose of inducing anesthesia, sedation, or unconsciousness 363
prior to euthanasia. Only those drugs that have been approved by 364
rule adopted in accordance with Chapter 119. of the Revised Code 365
by the state board of pharmacy, in consultation with the state 366
veterinary medical licensing board, may be used. 367
(C) No agent or employee of an animal shelter or wild 368
animal rehabilitation facility and no county dog warden or agent 369
or employee of a county dog warden, other than a registered 370
veterinary technician as defined in section 4741.01 of the 371
Revised Code, shall perform euthanasia by means of lethal 372
injection on an animal or administer pre-euthanasia drugs that 373
induce anesthesia, sedation, or unconsciousness unless the agent 374
or employee or county dog warden has received certification 375
after successfully completing a euthanasia technician 376
certification course as described in this division. 377
The curriculum for a euthanasia technician certification 378
course shall be one that has been approved by the state 379
veterinary medical licensing board, shall be at least sixteen 380
hours in length, and shall include information in at least all 381
of the following areas: 382
(1) The pharmacology, proper administration, and storage 383
of euthanasia, sedation, and anesthesia solutions; 384
(2) Federal and state laws regulating the storage and 385
accountability of euthanasia, sedation, and anesthesia 386
solutions; 387
(3) Euthanasia technician stress management; 388

Am. S. B. No. 152 Page 15
As Reported by the House Natural Resources Committee
(4) Proper disposal of euthanized animals. 389
(D)(1) No agent or employee of an animal shelter or wild 390
animal rehabilitation facility shall perform euthanasia by means 391
of lethal injection on animals or administer pre-euthanasia 392
drugs that induce anesthesia, sedation, or unconsciousness under 393
this section unless the facility in which the agent or employee 394
works or is employed is licensed with the state board of 395
pharmacy under section 4729.531 of the Revised Code. No agent or 396
employee of a county dog warden shall perform euthanasia by 397
means of lethal injection on animals or administer pre- 398
euthanasia drugs that induce anesthesia, sedation, or 399
unconsciousness under this section unless the county dog warden 400
is licensed under section 4729.531 of the Revised Code. 401
(2) Any agent or employee of an animal shelter or wild 402
animal rehabilitation facility or county dog warden performing 403
euthanasia by means of lethal injection or administering pre- 404
euthanasia drugs that induce anesthesia, sedation, or 405
unconsciousness shall do so only in a humane and proficient 406
manner that is in conformity with the methods described in 407
divisions (A) and (B) of this section and not in violation of 408
Chapter 959. of the Revised Code. 409
(E) Nothing in this section precludes a licensed 410
veterinarian or registered veterinary technician as defined in 411
section 4741.01 of the Revised Code from engaging in the 412
practice of veterinary medicine as authorized in Chapter 4741. 413
of the Revised Code. 414
Sec. 4729.54. (A) As used in this section: 415
(1) "Category II" means any dangerous drug that is not 416
included in category III. 417

Am. S. B. No. 152 Page 16
As Reported by the House Natural Resources Committee
(2) "Category III" means any controlled substance that is 418
contained in schedule I, II, III, IV, or V. 419
(3) "Emergency medical service organization" has the same 420
meaning as in section 4765.01 of the Revised Code. 421
(4) "Emergency medical service organization satellite" 422
means a location where dangerous drugs are stored that is 423
separate from, but associated with, the headquarters of an 424
emergency medical service organization. "Emergency medical 425
service organization satellite" does not include the units under 426
the control of the emergency medical service organization. 427
(5) "Person" includes an emergency medical service 428
organization or an emergency medical service organization 429
satellite. 430
(6) "Schedule I," "schedule II," "schedule III," "schedule 431
IV," and "schedule V" have the same meanings as in section 432
3719.01 of the Revised Code. 433
(B)(1) A person seeking to be licensed as a terminal 434
distributor of dangerous drugs shall file with the executive 435
director of the state board of pharmacy a verified application. 436
After it is filed, the application may not be withdrawn without 437
approval of the board. 438
(2) An application shall contain all the following that 439
apply in the applicant's case: 440
(a) Information that the board requires relative to the 441
qualifications of a terminal distributor of dangerous drugs set 442
forth in section 4729.55 of the Revised Code; 443
(b) A statement as to whether the person is seeking to be 444
licensed as a category II, category III, limited category II, or 445

Am. S. B. No. 152 Page 17
As Reported by the House Natural Resources Committee
limited category III terminal distributor of dangerous drugs; 446
(c) If the person is seeking to be licensed as a limited 447
category II or limited category III terminal distributor of 448
dangerous drugs, a list of the dangerous drugs that the person 449
is seeking to possess, have custody or control of, and 450
distribute, which list shall also specify the purpose for which 451
those drugs will be used and their source; 452
(d) If the person is an emergency medical service 453
organization, the information that is specified in divisions (C) 454
(1) and (2) of this section, and if the person is an emergency 455
medical service organization satellite, the information required 456
under division (D) of this section; 457
(e) Except with respect to the units under the control of 458
an emergency medical service organization, the identity of the 459
one establishment or place at which the person intends to engage 460
in the sale or other distribution of dangerous drugs at retail, 461
and maintain possession, custody, or control of dangerous drugs 462
for purposes other than the person's own use or consumption; 463
(f) If the application pertains to a pain management 464
clinic, information that demonstrates, to the satisfaction of 465
the board, compliance with division (A) of section 4729.552 of 466
the Revised Code. 467
(C)(1) Each emergency medical service organization that 468
applies for a terminal distributor of dangerous drugs license 469
shall submit with its application all of the following: 470
(a) A copy of its standing orders or protocol, which 471
orders or protocol shall be signed by a physician; 472
(b) A list of the dangerous drugs that the units under its 473
control may carry, expressed in standard dose units, which shall 474

Am. S. B. No. 152 Page 18
As Reported by the House Natural Resources Committee
be signed by a physician; 475
(c) A list of the personnel employed or used by the 476
organization to provide emergency medical services in accordance 477
with Chapter 4765. of the Revised Code. 478
In accordance with Chapter 119. of the Revised Code, the 479
board shall adopt rules specifying when an emergency medical 480
service organization that is licensed as a terminal distributor 481
must notify the board of any changes in its documentation 482
submitted pursuant to division (C)(1) of this section. 483
(2) An emergency medical service organization seeking to 484
be licensed as a terminal distributor of dangerous drugs shall 485
list in its application for licensure the following additional 486
information: 487
(a) The units under its control that the organization 488
determines will possess dangerous drugs for the purpose of 489
administering emergency medical services in accordance with 490
Chapter 4765. of the Revised Code; 491
(b) With respect to each such unit, whether the dangerous 492
drugs that the organization determines the unit will possess are 493
in category II or III. 494
(3) An emergency medical service organization that is 495
licensed as a terminal distributor of dangerous drugs shall file 496
a new application for such licensure if there is any change in 497
the number or location of any of its units or if there is any 498
change in the category of the dangerous drugs that any unit will 499
possess. 500
(4) A unit listed in an application for licensure pursuant 501
to division (C)(2) of this section may obtain the dangerous 502
drugs it is authorized to possess from its emergency medical 503

Am. S. B. No. 152 Page 19
As Reported by the House Natural Resources Committee
service organization or, on a replacement basis, from a hospital 504
pharmacy. If units will obtain dangerous drugs from a hospital 505
pharmacy, the organization shall file, and maintain in current 506
form, the following items with the pharmacist who is responsible 507
for the hospital's terminal distributor of dangerous drugs 508
license: 509
(a) A copy of its standing orders or protocol; 510
(b) A list of the personnel employed or used by the 511
organization to provide emergency medical services in accordance 512
with Chapter 4765. of the Revised Code, who are authorized to 513
possess the drugs, which list also shall indicate the personnel 514
who are authorized to administer the drugs. 515
(D) Each emergency medical service organization satellite 516
that applies for a terminal distributor of dangerous drugs 517
license shall submit with its application all of the information 518
that the board requires to be submitted with the application, as 519
specified in rules the board shall adopt in accordance with 520
Chapter 119. of the Revised Code. 521
(E) There shall be four categories of terminal distributor 522
of dangerous drugs licenses. The categories are as follows: 523
(1) Category II license. A person who obtains this license 524
may possess, have custody or control of, and distribute only the 525
dangerous drugs described in category II. 526
(2) Limited category II license. A person who obtains this 527
license may possess, have custody or control of, and distribute 528
only the dangerous drugs described in category II that were 529
listed in the application for licensure. 530
(3) Category III license, which may include a pain 531
management clinic classification issued under section 4729.552 532

Am. S. B. No. 152 Page 20
As Reported by the House Natural Resources Committee
of the Revised Code. A person who obtains this license may 533
possess, have custody or control of, and distribute the 534
dangerous drugs described in category II and category III. If 535
the license includes a pain management clinic classification, 536
the person may operate a pain management clinic. 537
(4) Limited category III license. A person who obtains 538
this license may possess, have custody or control of, and 539
distribute only the dangerous drugs described in category II or 540
category III that were listed in the application for licensure. 541
(F) Except for an application made by a county dog warden 542
or on behalf of an animal shelter or wild animal rehabilitation 543
facility, if an applicant for a limited category II license or 544
limited category III license intends to administer dangerous 545
drugs to a person or animal, the applicant shall submit, with 546
the application, a copy of its protocol or standing orders. The 547
protocol or orders shall be signed by a licensed health 548
professional authorized to prescribe drugs, specify the 549
dangerous drugs to be administered, and list personnel who are 550
authorized to administer the dangerous drugs in accordance with 551
federal law or the law of this state. 552
An application made by a county dog warden or on behalf of 553
an animal shelter or wild animal rehabilitation facility shall 554
include a list of the dangerous drugs to be administered to 555
animals and the personnel who are authorized to administer the 556
drugs to animals in accordance with section 4729.532 of the 557
Revised Code. 558
In accordance with Chapter 119. of the Revised Code, the 559
board shall adopt rules specifying when a licensee must notify 560
the board of any changes in its documentation submitted pursuant 561
to this division. 562

Am. S. B. No. 152 Page 21
As Reported by the House Natural Resources Committee
(G)(1) Except as provided in division (G)(3) of this 563
section, each applicant for licensure as a terminal distributor 564
of dangerous drugs shall submit, with the application, a license 565
fee. The amount assessed shall not be returned to the applicant 566
if the applicant fails to qualify for the license. 567
(2) The following fees apply under division (G)(1) of this 568
section: 569
(a) Except as provided in division (G)(2)(b) of this 570
section: 571
(i) Three hundred twenty dollars for a category II or 572
limited category II license; 573
(ii) Four hundred forty dollars for a category III 574
license, including a license with a pain management clinic 575
classification issued under section 4729.552 of the Revised 576
Code, or a limited category III license. 577
(b) One hundred twenty dollars for all of the following: 578
(i) A person who is required to hold a license as a 579
terminal distributor of dangerous drugs pursuant to division (C) 580
of section 4729.541 of the Revised Code; 581
(ii) A professional association, corporation, partnership, 582
or limited liability company organized for the purpose of 583
practicing veterinary medicine that is not included in division 584
(G)(2)(b)(i) of this section; 585
(iii) An emergency medical service organization satellite. 586
(3) No fee applies for a license issued to a charitable 587
pharmacy, as defined in section 3719.811 of the Revised Code, if 588
the charitable pharmacy is participating in the drug repository 589
program established under section 3715.87 of the Revised Code. 590

Am. S. B. No. 152 Page 22
As Reported by the House Natural Resources Committee
(H)(1) The board shall issue a terminal distributor of 591
dangerous drugs license to each person who submits an 592
application for such licensure in accordance with this section, 593
pays the required license fee, is determined by the board to 594
meet the requirements set forth in section 4729.55 of the 595
Revised Code, and satisfies any other applicable requirements of 596
this section. 597
(2) Except for the license of a county dog warden, the 598
license shall describe the one establishment or place at which 599
the licensee may engage in the sale or other distribution of 600
dangerous drugs at retail and maintain possession, custody, or 601
control of dangerous drugs for purposes other than the 602
licensee's own use or consumption. The one establishment or 603
place shall be that which is identified in the application for 604
licensure. 605
No such license shall authorize or permit the terminal 606
distributor of dangerous drugs named in it to engage in the sale 607
or other distribution of dangerous drugs at retail or to 608
maintain possession, custody, or control of dangerous drugs for 609
any purpose other than the distributor's own use or consumption, 610
at any establishment or place other than that described in the 611
license, except that an agent or employee of an animal shelter 612
or wild animal rehabilitation facility or county dog warden may 613
possess and use dangerous drugs in the course of business as 614
provided in section 4729.532 of the Revised Code. 615
(3) The license of an emergency medical service 616
organization shall cover the organization's headquarters and, in 617
addition, shall cover and describe all the units of the 618
organization listed in its application for licensure. 619
(I)(1) All licenses issued or renewed pursuant to this 620

Am. S. B. No. 152 Page 23
As Reported by the House Natural Resources Committee
section shall be effective for a period specified by the board 621
in rules adopted under section 4729.26 of the Revised Code. The 622
effective period for an initial or renewed license shall not 623
exceed twenty-four months unless the board extends the period in 624
rules to adjust license renewal schedules. A license shall be 625
renewed by the board according to the provisions of this 626
section, the standard renewal procedure of Chapter 4745. of the 627
Revised Code, and rules adopted by the board under section 628
4729.26 of the Revised Code. A person seeking to renew a license 629
shall submit an application for renewal and pay the required fee 630
on or before the date specified in the rules adopted by the 631
board. The fee required for the renewal of a license shall be 632
the same as the license fee that applies under division (G)(2) 633
of this section. 634
(2)(a) Subject to division (I)(2)(b) of this section, a 635
license that has not been renewed by the date specified in rules 636
adopted by the board may be reinstated only upon payment of the 637
required renewal fee and a penalty fee of one hundred ten 638
dollars. 639
(b) If an application for renewal has not been submitted 640
by the sixty-first day after the renewal date specified in rules 641
adopted by the board, the license is considered void and cannot 642
be renewed, but the license holder may reapply for licensure. 643
(3) A terminal distributor of dangerous drugs that fails 644
to renew licensure in accordance with this section and rules 645
adopted by the board is prohibited from engaging in the retail 646
sale, possession, or distribution of dangerous drugs until a 647
valid license is issued by the board. 648
(J)(1) No emergency medical service organization that is 649
licensed as a terminal distributor of dangerous drugs shall fail 650

Am. S. B. No. 152 Page 24
As Reported by the House Natural Resources Committee
to comply with division (C)(1), (3), or (4) of this section. 651
(2) No licensed terminal distributor of dangerous drugs 652
shall possess, have custody or control of, or distribute 653
dangerous drugs that the terminal distributor is not entitled to 654
possess, have custody or control of, or distribute by virtue of 655
its category of licensure. 656
(3) No licensee that is required by division (F) of this 657
section to notify the board of changes in its protocol or 658
standing orders, or in personnel, shall fail to comply with that 659
division. 660
(K) The board may enter into agreements with other states, 661
federal agencies, and other entities to exchange information 662
concerning licensing and inspection of terminal distributors of 663
dangerous drugs located within or outside this state and to 664
investigate alleged violations of the laws and rules governing 665
distribution of drugs by terminal distributors. Any information 666
received pursuant to such an agreement is subject to the same 667
confidentiality requirements applicable to the agency or entity 668
from which it was received and shall not be released without 669
prior authorization from that agency or entity. 670
Sec. 4729.55. No license shall be issued to an applicant 671
for licensure as a terminal distributor of dangerous drugs 672
unless the applicant has furnished satisfactory proof to the 673
state board of pharmacy that: 674
(A) The applicant is equipped as to land, buildings, and 675
equipment to properly carry on the business of a terminal 676
distributor of dangerous drugs within the category of licensure 677
approved by the board. 678
(B) One of the following will maintain supervision and 679

Am. S. B. No. 152 Page 25
As Reported by the House Natural Resources Committee
control over the possession and custody of dangerous drugs and 680
controlled substances that may be acquired by or on behalf of 681
the applicant: 682
(1) A pharmacist, licensed health professional authorized 683
to prescribe drugs, or other person authorized by the board,; 684
(2) An animal shelter, wild animal rehabilitation 685
facility, or county dog warden licensed under section 4729.531 686
of the Revised Code, or ; 687
(3) A laboratory will maintain supervision and control 688
over the possession and custody of dangerous drugs and 689
controlled substances that may be acquired by or on behalf of 690
the applicant. 691
(C) Adequate safeguards are assured to prevent the sale or 692
other distribution of dangerous drugs by any person other than a 693
pharmacist or licensed health professional authorized to 694
prescribe drugs. 695
(D) Adequate safeguards are assured that the applicant 696
will carry on the business of a terminal distributor of 697
dangerous drugs in a manner that allows pharmacists and pharmacy 698
interns employed by the terminal distributor to practice 699
pharmacy in a safe and effective manner. 700
(E) If the applicant, or any agent or employee of the 701
applicant, has been found guilty of violating section 4729.51 of 702
the Revised Code, the "Federal Food, Drug, and Cosmetic Act," 52 703
Stat. 1040 (1938), 21 U.S.C.A. 301, the federal drug abuse 704
control laws, Chapter 2925., 3715., 3719., or 4729. of the 705
Revised Code, or any rule of the board, adequate safeguards are 706
assured to prevent the recurrence of the violation. 707
(F) If the application is made on behalf of an animal 708

Am. S. B. No. 152 Page 26
As Reported by the House Natural Resources Committee
shelter, wild animal rehabilitation facility, or county dog 709
warden, at least one of the agents or employees of the animal 710
shelter or county dog warden is certified in compliance with 711
section 4729.532 of the Revised Code. 712
(G) In the case of an applicant who is a retail seller of 713
peritoneal dialysis solutions in original packages labeled as 714
required by the "Federal Food, Drug, and Cosmetic Act," 52 Stat. 715
1040 (1938), 21 U.S.C.A. 301, the applicant will maintain 716
supervision and control over the possession, custody, and retail 717
sale of the peritoneal dialysis solutions. 718
(H) In the case of an applicant who is a pain management 719
clinic, the applicant meets the requirements to receive a 720
license with a pain management clinic classification issued 721
under section 4729.552 of the Revised Code. 722
Section 2. That existing sections 4729.01, 4729.36, 723
4729.531, 4729.532, 4729.54, and 4729.55 of the Revised Code are 724
hereby repealed. 725

[DELETED: nA      .  :1 1 1 1 1 1 1 1]
[DELETED: 2  1 1 2 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4]
[DELETED: 2  4 4 4 4 4 5 5 5 5 5 5 5 5 5 5 6 6 6 6 6 6 6 6 6 6 7 7 7]
[DELETED: 2  7 7 7 7 7 7 7 8 8 8 8 8 8 8 8 8 8 9 9 9 9 9 9 9 9 9 9]
[DELETED: 2  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]
[DELETED: 2  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]
[DELETED: 2  1 1 1 1 1 1 1 1;1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]
[DELETED: 2  1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2]
[DELETED: 2  2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2]
[DELETED: 2  2 2 2 2 2 2.2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2]
[DELETED: 2  2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2:2;2 2 2 2 2.2 2 2 3 3]
[DELETED: 2  3 3 3 3 3.3 3 3 3 3.3 3 3 3 3 3 3 3 3 3 3 3 3.3 3 3:3 3 3 3]
[DELETED: 2  3 3 3;3 3 3;3 3 3.3 3 3 3 3 3 3 3 3.3 3 3 3 3:3;3;3 3;3]
[DELETED: 2 .3 3 3 3 3 3 3.3 3 3 3 3 3 3 3 3 3.3 3 3 3 3:3 3;3 3 3;3;3]
[DELETED: 2 .3 3 3 3 3 3 3 3 3-3 3 4.4 4 4-4 4 4 4 4.4 4 4 4 4.4 4 4 4]
[DELETED: 2  4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4]
[DELETED: 2  4 4 4 4 4 4 4 4)4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4]
[DELETED: 2  4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 5 5 5 5]
[DELETED: 2  5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5]
[DELETED: 2  5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5]
[DELETED: 2  5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5]
[DELETED: 2  5 5 5 5 5 5 5 5 5 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6]
[DELETED: 2  6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6]
[DELETED: 2  6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6.6 6 6 6 6 6 6 6 6 6]
[DELETED: 2  6 6:6 6;6 6 6;6 6 6 6 6 6 6 6 6 6 6 6 6 7 7 7 7 7 7 7 7 7]
[DELETED: 2  7 7 7 7 7 7 7 7 7 7 7 7 7.7 7 7.7]